Scope
Description
Supply of Apremilast; Denosumab; Pazopanib.
Total value (estimated)
- £12,307,059 excluding VAT
- £14,768,471 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 March 2026 to 29 February 2028
- Possible extension to 28 February 2030
- 4 years
Description of possible extension:
24 month extension option available
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKL - Wales
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Enquiry deadline
7 January 2026, 11:00am
Tender submission deadline
8 January 2026, 10:00am
Submission address and any special instructions
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
30 January 2026
Award criteria
| Name | Description | Type | Order of importance |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail |
Quality | 1 |
| Financial (overall cost of contract) | Weighting: 85 |
Cost | 2 |
| Enviromental/Social Value/Community Benefits | Weighting: 15 |
Quality | 3 |
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS Organisation Data Service: RQF
4-5 Charnwood Court,
Cardiff
CF14 3UZ
United Kingdom
Email: jennifer.tresilian@wales.nhs.uk
Website: http://nwssp.nhs.wales/ourservices/procurement-services/
Region: UKL22 - Cardiff and Vale of Glamorgan
Organisation type: Public authority - central government
Devolved regulations that apply: Wales